Insufficient scRNA-seq data for expression of DEFA4 at single-cell level.
Insufficient scRNA-seq data for expression of DEFA4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
spleen | 93% | 978.23 | 224 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 3794.52 | 751 / 929 | 0% | 0 | 0 / 0 |
lung | 78% | 293.34 | 452 / 578 | 1% | 0.28 | 16 / 1155 |
liver | 22% | 26.14 | 50 / 226 | 5% | 0.15 | 19 / 406 |
thymus | 12% | 6.08 | 78 / 653 | 11% | 1.17 | 66 / 605 |
heart | 15% | 12.65 | 133 / 861 | 0% | 0 | 0 / 0 |
adipose | 14% | 8.70 | 167 / 1204 | 0% | 0 | 0 / 0 |
breast | 13% | 6.29 | 58 / 459 | 1% | 0.01 | 7 / 1118 |
adrenal gland | 2% | 0.83 | 6 / 258 | 7% | 4.40 | 16 / 230 |
kidney | 6% | 2.02 | 5 / 89 | 3% | 0.17 | 29 / 901 |
brain | 6% | 2.52 | 156 / 2642 | 2% | 0.08 | 13 / 705 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.10 | 2 / 29 |
muscle | 5% | 2.50 | 42 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 3% | 2.45 | 45 / 1335 | 0% | 0 | 0 / 0 |
intestine | 2% | 5.85 | 21 / 966 | 1% | 0.02 | 4 / 527 |
esophagus | 2% | 1.45 | 30 / 1445 | 1% | 0.05 | 1 / 183 |
stomach | 1% | 0.77 | 4 / 359 | 1% | 0.04 | 4 / 286 |
pancreas | 0% | 0.31 | 1 / 328 | 2% | 0.02 | 3 / 178 |
uterus | 2% | 1.18 | 3 / 170 | 0% | 0 | 0 / 459 |
skin | 0% | 0.11 | 4 / 1809 | 1% | 0.02 | 6 / 472 |
ovary | 1% | 0.32 | 2 / 180 | 0% | 0.00 | 1 / 430 |
prostate | 0% | 0 | 0 / 245 | 1% | 0.01 | 4 / 502 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.01 | 4 / 504 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050832 | Biological process | defense response to fungus |
GO_0045087 | Biological process | innate immune response |
GO_0019731 | Biological process | antibacterial humoral response |
GO_0050829 | Biological process | defense response to Gram-negative bacterium |
GO_0019730 | Biological process | antimicrobial humoral response |
GO_0051673 | Biological process | disruption of plasma membrane integrity in another organism |
GO_0031640 | Biological process | killing of cells of another organism |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0002227 | Biological process | innate immune response in mucosa |
GO_0019732 | Biological process | antifungal humoral response |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0035580 | Cellular component | specific granule lumen |
GO_0005796 | Cellular component | Golgi lumen |
GO_0042582 | Cellular component | azurophil granule |
GO_0030133 | Cellular component | transport vesicle |
GO_0042803 | Molecular function | protein homodimerization activity |
Gene name | DEFA4 |
Protein name | Defensin alpha 4 (Corticostatin HP-4) (HNP-4) (HP-4) (Neutrophil defensin 4) |
Synonyms | DEF4 |
Description | FUNCTION: Host-defense peptide that has antimicrobial activity against Gram-negative bacteria, and to a lesser extent also against Gram-positive bacteria and fungi . Exhibits antimicrobial activity against Gram-negative E.coli and E.aerogenes and Gram-positive S.faecalis, S.aureus and B.cereus and the yeast C.albicans (in vitro) . Interacts with pathogenic surface proteins and toxins, such as HIV-1 surface protein gp120 and B.anthracis anthrax lethal factor lef . Protects blood cells against infection with HIV-1 (in vitro) . Inhibits enzymatic activity of B.anthracis lef/anthrax lethal factor (in vitro) . Inhibits corticotropin (ACTH)-stimulated corticosterone production (in vitro) . . |
Accessions | P12838 ENST00000642522.2 ENST00000297435.3 |